Conmed Stock Filter Stocks by Fundamentals
| CNMD Stock | USD 62.15 0.16 0.26% |
CONMED fundamentals help investors to digest information that contributes to CONMED's financial success or failures. It also enables traders to predict the movement of CONMED Stock. The fundamental analysis module provides a way to measure CONMED's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CONMED stock.
CONMED | Shares Owned by Institutions |
CONMED ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, CONMED's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to CONMED's managers, analysts, and investors.Environmental | Governance | Social |
CONMED Institutional Holders
Institutional Holdings refers to the ownership stake in CONMED that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of CONMED's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing CONMED's value.| Shares | Geode Capital Management, Llc | 2024-06-30 | 685.1 K | Deerfield Management Co | 2024-06-30 | 631.3 K | Cooke & Bieler Lp | 2024-06-30 | 628.6 K | Principal Financial Group Inc | 2024-06-30 | 595.7 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 577.7 K | Millennium Management Llc | 2024-06-30 | 547.6 K | Arrowmark Colorado Holdings, Llc (arrowmark Partners) | 2024-06-30 | 497.8 K | Wells Fargo & Co | 2024-06-30 | 424.9 K | Clearbridge Advisors, Llc | 2024-06-30 | 421.5 K | Blackrock Inc | 2024-06-30 | 5 M | Vanguard Group Inc | 2024-06-30 | 3.5 M |
CONMED Fundamentals
| Return On Equity | 0.12 | ||||
| Return On Asset | 0.0392 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.12 % | ||||
| Current Valuation | 2.85 B | ||||
| Shares Outstanding | 30.83 M | ||||
| Shares Owned By Insiders | 0.56 % | ||||
| Shares Owned By Institutions | 99.44 % | ||||
| Number Of Shares Shorted | 846.97 K | ||||
| Price To Earning | 188.03 X | ||||
| Price To Book | 2.17 X | ||||
| Price To Sales | 1.51 X | ||||
| Revenue | 1.24 B | ||||
| Gross Profit | 575.75 M | ||||
| EBITDA | 182.19 M | ||||
| Net Income | 64.46 M | ||||
| Cash And Equivalents | 33.35 M | ||||
| Cash Per Share | 1.09 X | ||||
| Total Debt | 991.25 M | ||||
| Debt To Equity | 1.45 % | ||||
| Current Ratio | 2.75 X | ||||
| Book Value Per Share | 28.61 X | ||||
| Cash Flow From Operations | 125.35 M | ||||
| Short Ratio | 6.05 X | ||||
| Earnings Per Share | 3.14 X | ||||
| Price To Earnings To Growth | 5.29 X | ||||
| Target Price | 83.71 | ||||
| Number Of Employees | 4 K | ||||
| Beta | 1.46 | ||||
| Market Capitalization | 1.92 B | ||||
| Total Asset | 2.3 B | ||||
| Retained Earnings | 452.53 M | ||||
| Working Capital | 304.92 M | ||||
| Current Asset | 393.34 M | ||||
| Current Liabilities | 119.72 M | ||||
| Annual Yield | 0.01 % | ||||
| Five Year Return | 0.92 % | ||||
| Net Asset | 2.3 B | ||||
| Last Dividend Paid | 0.8 |
About CONMED Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CONMED's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CONMED using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CONMED based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| MSFT | Microsoft | |
| V | Visa Class A | |
| MSFT | Microsoft |
Check out CONMED Piotroski F Score and CONMED Altman Z Score analysis. For information on how to trade CONMED Stock refer to our How to Trade CONMED Stock guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CONMED. If investors know CONMED will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CONMED listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.233 | Dividend Share 0.8 | Earnings Share 3.14 | Revenue Per Share 41.468 | Quarterly Revenue Growth 0.045 |
The market value of CONMED is measured differently than its book value, which is the value of CONMED that is recorded on the company's balance sheet. Investors also form their own opinion of CONMED's value that differs from its market value or its book value, called intrinsic value, which is CONMED's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CONMED's market value can be influenced by many factors that don't directly affect CONMED's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CONMED's value and its price as these two are different measures arrived at by different means. Investors typically determine if CONMED is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CONMED's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.